|
MRPS6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23719999999927E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.4362E-05 |
| Normal-vs-Stage2 |
1.9096099999949E-05 |
| Normal-vs-Stage3 |
2.14169999999125E-05 |
| Normal-vs-Stage4 |
1.87554999999673E-05 |
| Stage1-vs-Stage2 |
5.656300E-02 |
| Stage1-vs-Stage3 |
4.023200E-01 |
| Stage1-vs-Stage4 |
3.887400E-01 |
| Stage2-vs-Stage3 |
5.354000E-01 |
| Stage2-vs-Stage4 |
8.448400E-01 |
| Stage3-vs-Stage4 |
5.751000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19369999999719E-05 |
| Normal-vs-AfricanAmerican |
2.49799999999523E-05 |
| Normal-vs-Asian |
1.83864999999672E-05 |
| Caucasian-vs-AfricanAmerican |
4.241800E-01 |
| Caucasian-vs-Asian |
1.669580E-01 |
| AfricanAmerican-vs-Asian |
6.670200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07879999999383E-05 |
| Normal-vs-Female |
3.91250000000287E-05 |
| Male-vs-Female |
6.907700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.98040000000321E-05 |
| Normal-vs-Extreme_Weight |
2.18629999999553E-05 |
| Normal-vs-Obese |
2.23779999999341E-05 |
| Normal-vs-Extreme_Obese |
2.01129999999328E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.046200E-01 |
| Normal_Weight-vs-Obese |
3.525000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.098600E-01 |
| Extreme_Weight-vs-Obese |
8.832200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.496400E-01 |
| Obese-vs-Extreme_Obese |
5.180000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.6075999999996E-05 |
| Normal-vs-Age(41-60Yrs) |
2.36539999999286E-05 |
| Normal-vs-Age(61-80Yrs) |
2.22890000000087E-05 |
| Normal-vs-Age(81-100Yrs) |
1.57953999999627E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.216200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.382800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.763600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.547400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.215700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.585820E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17479999999881E-05 |
| Normal-VS-Type2 PRCC |
2.00969999999412E-05 |
| Normal-VS-KIRP CIMP |
1.008480E-04 |
| Normal-VS-Unclassified PRCC |
1.79214000000094E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.614000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.143600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.211600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.519300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.554200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.722000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61931999999032E-05 |
| Normal-vs-N1 |
1.84372999999516E-05 |
| Normal-vs-N2 |
2.0923000000006E-05 |
| N0-vs-N1 |
2.413600E-01 |
| N0-vs-N2 |
9.330000E-01 |
| N1-vs-N2 |
6.726000E-01 |
|
|
